Join
Live feed
·
PRReleasevia Quantisnow
Passage Bio Inc. logo

Passage Bio Out-licenses Three Pediatric Gene Therapy Programs to GEMMA Biotherapeutics and Enters New Research Collaboration

ByQuantisnow·Wall Street's wire, on your screen.
PASG· Passage Bio Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PASG (Passage Bio Inc.) and more on Quantisnow.